All In MedTech

Device Trial Radar · NCT02224859

Invictus Medical, Medical Cranial Support Device (CSD) is a Device Safety Study in Infants at Risk of Head Ulcers.

Clinical Safety and Utility of the Invictus Cranial Support Device (CSD)

Last checked: Nov 21, 2026Latest source record: Mar 24, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Mar 2014

Primary completion

Jan 2015

Study completion Jan 2015

Sponsor

Lead sponsor
Invictus Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 25, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Who can join
All sexes, from 30 weeks, up to 36 weeks
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

While using the device as a cushion, the passive distribution of pressure over bony skull prominences of infants will protect against formation of pressure ulcers.

Conditions

  • Other Preterm Infants

Interventions

  • HCP will place the Invictus Cranial Support Device (CSD) on the patientDevice

    There is no active therapeutic treatment (e.g., medication, stimulation, etc.) associated with this device or study. All supplies for this study will be supplied by the sponsor and returned to them upon completion of the trial. The device used in this study is a soft gel based bonnet referred to as a Cranial Support Device (CSD). In this study, after obtaining written informed consent from the patient's parent(s) or guardian(s) and confirming that the patient meets all inclusion and no exclusion criteria, the study HCP will place the CSD on the selected patient.

  • human interventionOther

    This study is designed to evaluate the safety of the Invictus Cranial Support Device (CSD) when worn by medically stable infants within a neonatal intensive care unit (NICU), to evaluate the form, fit, and ease of use/application of the CSD device (i.e., utility), as well as initial impressions of safety, by health care providers (HCPs) after placing the current CSD on infants for approximately six (6) hours in a NICU

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HCP assessments of the products form, fit, likely effectiveness, and safety for internal decision making and for support of an FDA 510K submission to demonstrate form and fit as it relates to a predicate device.Time frame: Each patient will spend approximately six (6) hours in the study if no adverse experiences

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Baylor University Medical Center

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.